| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023994752 |
| P356 | DOI | 10.1038/JHH.2014.36 |
| P698 | PubMed publication ID | 24804791 |
| P5875 | ResearchGate publication ID | 262145927 |
| P2093 | author name string | W Nadruz | |
| P2860 | cites work | Is cardiac hypertrophy a required compensatory mechanism in pressure-overloaded heart? | Q60153632 |
| Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis | Q61868310 | ||
| Diabetic cardiomyopathy | Q82636239 | ||
| Leg blood pressure measured in orthostatic posture is associated with left ventricular mass in normotensive subjects | Q84587074 | ||
| Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction | Q84588530 | ||
| Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up | Q84613756 | ||
| Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
| LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice | Q30451602 | ||
| The hypertensive heart. An integrated understanding informed by imaging | Q30477597 | ||
| Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease | Q30577730 | ||
| Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling | Q30659130 | ||
| Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling | Q33862454 | ||
| Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways | Q33951680 | ||
| Prognostic implications of left ventricular hypertrophy | Q34169883 | ||
| Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches | Q34980057 | ||
| Genes for left ventricular hypertrophy | Q35670654 | ||
| Patterns of left ventricular hypertrophy in essential hypertension: should echocardiography guide the pharmacological treatment? | Q36805387 | ||
| Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? | Q36843771 | ||
| Left ventricular hypertrophy and clinical outcomes in hypertensive patients | Q37147735 | ||
| Relations of biomarkers representing distinct biological pathways to left ventricular geometry | Q37355268 | ||
| Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction | Q37434977 | ||
| Towards a new paradigm about hypertensive heart disease | Q37475565 | ||
| The progression of hypertensive heart disease | Q37832070 | ||
| Pressure overload | Q37959774 | ||
| Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies | Q37960351 | ||
| Salt and hypertension: is salt dietary reduction worth the effort? | Q38000672 | ||
| Left ventricular geometry in obesity: Is it what we expect? | Q38149591 | ||
| The cellular and molecular response of cardiac myocytes to mechanical stress. | Q41388060 | ||
| Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study | Q43514908 | ||
| Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study | Q43818857 | ||
| Left ventricular remodeling impairs coronary flow reserve in hypertensive patients | Q44072781 | ||
| Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). | Q46587540 | ||
| Brachial blood pressure-independent relations between radial late systolic shoulder-derived aortic pressures and target organ changes. | Q46665342 | ||
| Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension | Q52455174 | ||
| P433 | issue | 1 | |
| P921 | main subject | arterial hypertension | Q41861 |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2014-05-08 | |
| P1433 | published in | Journal of Human Hypertension | Q15746469 |
| P1476 | title | Myocardial remodeling in hypertension | |
| P478 | volume | 29 |
| Q92542032 | A Contemporary Look at Biomechanical Models of Myocardium |
| Q37241927 | A peptide of the RGS domain of GRK2 binds and inhibits Gα(q) to suppress pathological cardiac hypertrophy and dysfunction |
| Q26827482 | Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs |
| Q33829555 | Association of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population |
| Q30248624 | Cardiac Imaging in Heart Failure with Comorbidities |
| Q50918490 | Cardiomyocyte loss is not required for the progression of left ventricular hypertrophy induced by pressure overload in female mice. |
| Q93196127 | Cardiovascular and Autonomic Dysfunction in Murine Ligature-Induced Periodontitis |
| Q36476890 | Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress |
| Q35003747 | Developmental programming of cardiovascular disease following intrauterine growth restriction: findings utilising a rat model of maternal protein restriction. |
| Q57486424 | Disease Modifiers of Inherited Channelopathy |
| Q64069812 | Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up |
| Q37299336 | Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study |
| Q38640417 | Effect of increased left ventricle mass on ischemia assessment in electrocardiographic signals: rabbit isolated heart study. |
| Q37206993 | Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy |
| Q48146412 | Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. |
| Q60918005 | Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival |
| Q47179239 | Impact of echocardiography on one-month and one-year mortality of intertrochanteric fracture patients |
| Q64062233 | Impact of medical therapy for cardiovascular disease on left ventricular diastolic properties and remodeling |
| Q46562871 | Impaired ADP channeling to mitochondria and elevated reactive oxygen species in hypertensive hearts |
| Q100694519 | Left ventricular remodeling and dysfunction in primary aldosteronism |
| Q33647436 | MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant Hypertension |
| Q46323757 | Melatonin, mitochondria and hypertension. |
| Q51787118 | MicroRNAs Mediate Beneficial Effects of Exercise in Heart. |
| Q38667230 | Mitochondrial Function in Engineered Cardiac Tissues is Co-Regulated by Extracellular Matrix Elasticity and Tissue Alignment. |
| Q100513955 | Mitochondrial architecture in cardiac myocytes depends on cell shape and matrix rigidity |
| Q54276311 | Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy. |
| Q28073418 | Obesity and hypertensive heart disease: focus on body composition and sex differences |
| Q86084936 | Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation |
| Q98190320 | Overweight during lactation and its implications for biometric, nutritional and cardiovascular parameters of young and adult male and female rats |
| Q26744232 | Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases |
| Q47110146 | Prognostic Application of Thoracic Aortic Calcium Scoring for Adverse Clinical Outcome Risk in Elderly Patients with Left Ventricular Hypertrophy |
| Q92858785 | Randomised, double-blind, placebo-controlled clinical trial investigating the effects of inorganic nitrate in hypertension-induced target organ damage: protocol of the NITRATE-TOD study in the UK |
| Q47703503 | Regression of Left Ventricular Mass After Bariatric Surgery |
| Q47682969 | Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases |
| Q34966315 | SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy |
| Q51446637 | Serum biochemistry profile, inflammatory cytokines, adipokines and cardiovascular findings in obese dogs. |
| Q37661093 | Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats. |
| Q89451828 | Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? |
| Q51620512 | The CD147/MMP-2 signaling pathway may regulate early stage cardiac remodelling in spontaneously hypertensive rats. |
| Q92617396 | The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats |
| Q47249639 | VCP represses pathological cardiac hypertrophy |
| Q89637381 | Vascular, cardiac and renal target organ damage associated to arterial hypertension: which noninvasive tools for detection? |
Search more.